A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Clinical trial NCT06767748 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06767748
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-15
- Primary completion
- 2026-02-07
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.